Found 796 results
[ Author(Desc)] Keyword Title Type Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Traber MG, Elsner A, Brigelius-Flohé R.  1998.  Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates.. FEBS Lett. 437(1-2):145-8.
Traber MG, Siddens LK, Leonard SW, Schock B, Gohil K, Krueger SK, Cross CE, Williams DE.  2005.  Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets.. Free Radic Biol Med. 38(6):773-85.
Traber MG.  2004.  Vitamin E, nuclear receptors and xenobiotic metabolism.. Arch Biochem Biophys. 423(1):6-11.
Traber MG, Leonard SW, Ebenuwa I, Violet P-C, Niyyati M, Padayatty S, Smith S, Bobe G, Levine M.  2020.  Vitamin E catabolism in women, as modulated by food and by fat, studied using 2 deuterium-labeled α-tocopherols in a 3-phase, nonrandomized crossover study.. Am J Clin Nutr.
Traber MG, Mah E, Leonard SW, Bobe G, Bruno RS.  2017.  Metabolic syndrome increases dietary α-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial.. Am J Clin Nutr. 105(3):571-579.
Traber MG, Mustacich DJ, Sullivan LC, Leonard SW, Ahern-Rindell A, Kerkvliet N.  2010.  Vitamin E status and metabolism in adult and aged aryl hydrocarbon receptor null mice.. J Nutr Biochem. 21(12):1193-9.
Traber MG.  2001.  Does vitamin E decrease heart attack risk? summary and implications with respect to dietary recommendations. J Nutr. 131(2):395S-7S.
Traber MG, Shimoda K, Murakami K, Leonard SW, Enkhbaatar P, Traber LD, Traber DL.  2007.  Burn and smoke inhalation injury in sheep depletes vitamin E: kinetic studies using deuterated tocopherols.. Free Radic Biol Med. 42(9):1421-9.
Traber MG, Arai H.  1999.  Molecular mechanisms of vitamin E transport.. Annu Rev Nutr. 19:343-55.
Traber MG, Cross CE.  2023.  Alpha-Tocopherol from People to Plants Is an Essential Cog in the Metabolic Machinery.. Antioxid Redox Signal. 38(10-12):775-791.
Traber MG, Leonard SW, Ebenuwa I, Violet P-C, Wang Y, Niyyati M, Padayatty S, Tu H, Courville A, Bernstein S et al..  2019.  Vitamin E absorption and kinetics in healthy women, as modulated by food and by fat, studied using 2 deuterium-labeled α-tocopherols in a 3-phase crossover design.. Am J Clin Nutr. 110(5):1148-1167.
Traber MG, Buettner GR, Bruno RS.  2019.  The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome.. Redox Biol. 21:101091.
Traber MG.  1998.  Recent advances of vitamin E pathophysiology.. Asia Pac J Clin Nutr. 7(3/4):262-9.
Traber MG.  2021.  Vitamin E: necessary nutrient for neural development and cognitive function.. Proc Nutr Soc. :1-8.
Traber MG.  2010.  Regulation of xenobiotic metabolism, the only signaling function of alpha-tocopherol? Mol Nutr Food Res. 54(5):661-8.
Traber MG, Frei B, Beckman JS.  2008.  Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr Opin Lipidol. 19(1):30-8.
Traber MG, Labut EM, Leonard SW, Lebold KM.  2011.  α-Tocopherol injections in rats up-regulate hepatic ABC transporters, but not cytochrome P450 enzymes.. Free Radic Biol Med. 51(11):2031-40.
Traber MG.  2024.  Human Vitamin E deficiency, and what is and is not Vitamin E? Free Radic Biol Med. 213:285-292.
Traber MG, van der Vliet A, Reznick AZ, Cross CE.  2000.  Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? Clin Chest Med. 21(1):173-87,x.
Traber MG, Burton GW, Hamilton RL.  2004.  Vitamin E trafficking.. Ann N Y Acad Sci. 1031:1-12.
Traber MG.  2007.  Heart disease and single-vitamin supplementation.. Am J Clin Nutr. 85(1):293S-299S.
Traber MG.  1999.  Utilization of vitamin E.. Biofactors. 10(2-3):115-20.
Trias E, Kovacs M, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, Moura IC, Hermine O, Beckman JS et al..  2020.  Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.. Glia. 68(6):1165-1181.
Trias E, Ibarburu S, Barreto-Núñez R, Babdor J, Maciel TT, Guillo M, Gros L, Dubreuil P, Díaz-Amarilla P, Cassina P et al..  2016.  Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.. J Neuroinflammation. 13(1):177.
Trias E, Beilby PR, Kovacs M, Ibarburu S, Varela V, Barreto-Núñez R, Bradford SC, Beckman JS, Barbeito L.  2019.  Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS.. Front Aging Neurosci. 11:42.

Pages